Apceth GmbH & Co. KG
🇩🇪Germany
Clinical Trials
6
Active:3
Completed:2
Trial Phases
1 Phases
Phase 1:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (100.0%)Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Apceth GmbH & Co. KG
- Target Recruit Count
- 13
- Registration Number
- NCT02008539
- Locations
- 🇩🇪
University Hospital Munich, Munich, Germany
Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia
Phase 1
Completed
- Conditions
- Critical Limb IschemiaPeripheral Artery Disease
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2015-12-15
- Lead Sponsor
- Apceth GmbH & Co. KG
- Target Recruit Count
- 25
- Registration Number
- NCT01351610
- Locations
- 🇩🇪
Isar Medizin Zentrum, Munich, Bavaria, Germany
News
No news found